Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease
Clinical trial NCT04109300 · UNKNOWN
Trial details
- NCT number
- NCT04109300
- Sponsor
- Western University, Canada
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.